Intra-tumoral application of a heregulin-exotoxin-A fusion protein causes rapid tumor regression without adverse systemic or local effects
Open Access
- 17 March 1997
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 70 (6) , 682-687
- https://doi.org/10.1002/(sici)1097-0215(19970317)70:6<682::aid-ijc10>3.0.co;2-c
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Involvement of the neuregulins and their receptors in cardiac and neural developmentBioEssays, 1996
- A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptorInternational Journal of Cancer, 1996
- ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate.The EMBO Journal, 1995
- A target for tumour-directed therapyNature Medicine, 1995
- The Structural Basis for the Specificity of Epidermal Growth Factor and Heregulin BindingPublished by Elsevier ,1995
- Intrathecal administration of single-chain immunotoxin, LMB-7 [B3(Fv)-PE38], produces cures of carcinomatous meningitis in a rat model.Proceedings of the National Academy of Sciences, 1995
- HER4 Expression Correlates with Cytotoxicity Directed by a Heregulin-Toxin Fusion ProteinPublished by Elsevier ,1995
- Recent developments in immunotoxin therapyCurrent Opinion in Immunology, 1994
- Targeted toxins as anticancer agentsCancer, 1994
- Neu and its ligands: From an oncogene to neural factorsBioEssays, 1993